entinostat has been researched along with Cancer of Head in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves Avelar, LA | 1 |
| Schrenk, C | 1 |
| Sönnichsen, M | 1 |
| Hamacher, A | 1 |
| Hansen, FK | 1 |
| Schliehe-Diecks, J | 1 |
| Borkhardt, A | 1 |
| Bhatia, S | 1 |
| Kassack, MU | 1 |
| Kurz, T | 1 |
| Marques, AEM | 1 |
| do Nascimento Filho, CHV | 1 |
| Marinho Bezerra, TM | 1 |
| Guerra, ENS | 1 |
| Castilho, RM | 1 |
| Squarize, CH | 1 |
2 other studies available for entinostat and Cancer of Head
| Article | Year |
|---|---|
Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Drug Synergism; Epigenomics; Head and Neck Neoplasms; Histone Deac | 2021 |
Entinostat is a novel therapeutic agent to treat oral squamous cell carcinoma.
Topics: Apoptosis; Benzamides; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; H | 2020 |